Biomedical Advanced Research and Development Authority (BARDA), which evolved out of the biodefense-focused Project BioShield, has moved beyond simply funding drugs and devices that might be used in the event of terrorism. The division of the U.S. Department of Health and Human Services now prefers to help develop dual-use products that can have an immediate benefit to public health as well as a guarding against potential terrorism.